Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company serves generic companies, regional and domestic pharmaceutical manufacturers, distributors, and other pharmaceutical and biotechnology companies. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Key Metrics
as of Sep 2026
Market Cap 29,034 Cr
P/E 58.30
Div Yield 0.15 %
Book Value βΉ1,461.00
52w High βΉ23,899.00
52w Low βΉ11,500.00
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
642.00
776.00
440.00
514.00
293.00
328.00
398.00
311.00
440.00
385.00
393.00
418.00
363.00
Expenses
419.00
469.00
363.00
359.00
258.00
277.00
311.00
249.00
316.00
278.00
272.00
280.00
266.00
Operating Profit
223.00
307.00
77.00
156.00
34.00
51.00
87.00
62.00
123.00
107.00
121.00
137.00
97.00
OPM %
35.00
40.00
18.00
30.00
12.00
16.00
22.00
20.00
28.00
28.00
31.00
33.00
27.00
Other Income
8.00
12.00
8.00
2.00
8.00
7.00
60.00
4.00
25.00
5.00
2.00
3.00
2.00
Depreciation
27.00
25.00
24.00
23.00
20.00
17.00
16.00
16.00
16.00
16.00
15.00
15.00
14.00
Interest
7.00
7.00
7.00
5.00
5.00
2.00
2.00
1.00
3.00
4.00
4.00
4.00
2.00
Profit before tax
198.00
287.00
54.00
129.00
18.00
39.00
128.00
49.00
130.00
92.00
104.00
122.00
83.00
Tax %
25.00
26.00
26.00
25.00
21.00
29.00
20.00
34.00
25.00
27.00
22.00
27.00
26.00
Net Profit
148.00
213.00
41.00
97.00
14.00
28.00
102.00
33.00
98.00
68.00
81.00
89.00
62.00
EPS in Rs
115.10
165.76
31.62
75.49
10.83
21.68
79.18
25.60
76.28
52.66
63.44
69.56
48.23
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
2,023.00 1,477.00 1,559.00 1,191.00 951.00 937.00 763.00 667.00 527.00 579.00 510.00 469.00
Expenses
1,443.00 1,146.00 1,096.00 918.00 807.00 790.00 661.00 608.00 477.00 472.00 430.00 402.00
Operating Profit
580.00 331.00 463.00 273.00 144.00 147.00 102.00 58.00 51.00 106.00 80.00 67.00
OPM %
29.00 22.00 30.00 23.00 15.00 16.00 13.00 9.00 10.00 18.00 16.00 14.00
Other Income
25.00 90.00 12.00 9.00 0.00 16.00 4.00 3.00 4.00 1.00 2.00 0.00
Interest
24.00 8.00 14.00 13.00 14.00 18.00 22.00 16.00 19.00 21.00 24.00 27.00
Depreciation
92.00 66.00 60.00 53.00 49.00 40.00 31.00 26.00 22.00 19.00 16.00 15.00
Profit before tax
489.00 346.00 401.00 216.00 82.00 105.00 53.00 20.00 14.00 67.00 42.00 25.00
Tax %
26.00 25.00 25.00 24.00 22.00 23.00 69.00 19.00 13.00 30.00 36.00 36.00
Net Profit
364.00 260.00 300.00 164.00 64.00 81.00 16.00 16.00 12.00 47.00 27.00 16.00
EPS in Rs
283.71 202.74 233.89 127.45 49.74 62.85 12.63 12.81 13.57 52.74 30.75 17.96
Dividend Payout %
12.00 6.00 6.00 8.00 10.00 8.00 16.00 0.00 0.00 0.00 7.00 8.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
13.00 13.00 13.00 13.00 13.00 13.00 13.00 13.00 9.00 9.00 9.00 9.00
Reserves
1,862.00 1,512.00 1,270.00 981.00 828.00 774.00 697.00 686.00 549.00 537.00 178.00 152.00
Borrowings
301.00 157.00 95.00 128.00 241.00 182.00 264.00 231.00 319.00 192.00 182.00 188.00
Other Liabilities
754.00 498.00 454.00 457.00 302.00 356.00 257.00 200.00 194.00 148.00 155.00 162.00
Total Liabilities
2,930.00 2,180.00 1,833.00 1,580.00 1,383.00 1,325.00 1,231.00 1,130.00 1,071.00 886.00 524.00 512.00
Fixed Assets
1,177.00 955.00 824.00 758.00 767.00 716.00 653.00 542.00 475.00 466.00 139.00 123.00
CWIP
211.00 48.00 46.00 41.00 20.00 17.00 24.00 104.00 126.00 20.00 40.00 41.00
Investments
2.00 109.00 1.00 1.00 4.00 7.00 8.00 8.00 8.00 8.00 7.00 7.00
Other Assets
1,541.00 1,068.00 962.00 781.00 592.00 585.00 547.00 476.00 463.00 393.00 337.00 340.00
Total Assets
2,930.00 2,180.00 1,833.00 1,580.00 1,383.00 1,325.00 1,231.00 1,130.00 1,071.00 886.00 524.00 512.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
347.00 317.00 261.00 237.00 60.00 189.00 57.00 70.00 11.00 39.00 45.00 13.00
Cash from Investing Activity
-423.00 -298.00 -150.00 -61.00 -95.00 -84.00 -49.00 -77.00 -116.00 -42.00 -20.00 -14.00
Cash from Financing Activity
21.00 25.00 -69.00 -136.00 38.00 -114.00 -5.00 12.00 105.00 0.00 -24.00 1.00
Net Cash Flow
-55.00 44.00 42.00 40.00 3.00 -9.00 3.00 5.00 0.00 -4.00 1.00 0.00
Free Cash Flow
-50.00 112.00 119.00 173.00 -37.00 84.00 9.00 7.00 -121.00 -2.00 26.00 -1.00
CFO/OP %
78.00 119.00 81.00 103.00 56.00 132.00 61.00 128.00 28.00 52.00 70.00 33.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
98.00 78.00 87.00 111.00 90.00 85.00 91.00 90.00 134.00 114.00 85.00 100.00
Inventory Days
245.00 238.00 220.00 211.00 227.00 205.00 209.00 191.00 266.00 186.00 182.00 170.00
Days Payable
129.00 156.00 121.00 129.00 100.00 126.00 110.00 118.00 189.00 118.00 121.00 167.00
Cash Conversion Cycle
214.00 160.00 187.00 193.00 216.00 164.00 190.00 162.00 211.00 182.00 147.00 103.00
Working Capital Days
75.00 76.00 88.00 81.00 74.00 60.00 137.00 138.00 38.00 44.00 26.00 11.00
ROCE %
26.00 19.00 33.00 21.00 10.00 11.00 8.00 4.00 4.00 16.00 18.00 16.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
32.62
32.63
32.63
32.64
32.67
32.67
32.68
32.64
32.72
32.74
32.80
35.97
FIIs
21.08
20.46
20.90
20.60
21.69
22.12
23.86
26.46
25.72
24.43
22.69
21.57
DIIs
16.52
15.84
14.72
13.55
11.57
10.97
9.09
6.38
6.39
6.54
6.02
6.99
Public
29.79
31.08
31.76
32.80
33.67
33.85
33.96
34.12
34.77
35.88
38.10
35.08
No. of Shareholders
44,340
46,304
46,187
44,393
42,419
39,333
39,315
34,567
29,077
28,616
27,723
26,824
Corporate Actions
30 records
Back to all stocks